TY - JOUR
T1 - A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome
AU - Torisu, Hiroyuki
AU - Kira, Ryutaro
AU - Kanazawa, Naomi
AU - Takemoto, Megumi
AU - Sanefuji, Masafumi
AU - Sakai, Yasunari
AU - Tsujino, Seiichi
AU - Hara, Toshiro
PY - 2006/6
Y1 - 2006/6
N2 - The hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (MIM 238970) is an autosomal recessive metabolic disorder caused by a deficiency of the mitochondrial ornithine transporter, one of the urea cycle components. Mutations in the SLC25A15 gene have been coupled to the HHH syndrome. We describe a Japanese female patient with the HHH syndrome due to a novel homozygous R275X SLC25A15 mutation and male sibling who presumably carried the same mutation. He exhibited slowly progressive deterioration with seizures, a gait disturbance due to polyneuropathy, episodic confusion, and died of acute encephalopathy at 34 years of age while the proband exhibited moderate mental retardation, seizures, mild spastic paraplegia, and deafness without neurological deterioration for more than 20 years. The clinical features of previously documented patients with the homozygous SLC25A15 mutation demonstrated that genotype did not simply correlate with clinical severity. The phenotypic variability might depend on other factors, such as dietary and other genetic ones.
AB - The hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (MIM 238970) is an autosomal recessive metabolic disorder caused by a deficiency of the mitochondrial ornithine transporter, one of the urea cycle components. Mutations in the SLC25A15 gene have been coupled to the HHH syndrome. We describe a Japanese female patient with the HHH syndrome due to a novel homozygous R275X SLC25A15 mutation and male sibling who presumably carried the same mutation. He exhibited slowly progressive deterioration with seizures, a gait disturbance due to polyneuropathy, episodic confusion, and died of acute encephalopathy at 34 years of age while the proband exhibited moderate mental retardation, seizures, mild spastic paraplegia, and deafness without neurological deterioration for more than 20 years. The clinical features of previously documented patients with the homozygous SLC25A15 mutation demonstrated that genotype did not simply correlate with clinical severity. The phenotypic variability might depend on other factors, such as dietary and other genetic ones.
UR - http://www.scopus.com/inward/record.url?scp=33646103667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646103667&partnerID=8YFLogxK
U2 - 10.1016/j.braindev.2005.10.002
DO - 10.1016/j.braindev.2005.10.002
M3 - Article
C2 - 16376511
AN - SCOPUS:33646103667
SN - 0387-7604
VL - 28
SP - 332
EP - 335
JO - Brain and Development
JF - Brain and Development
IS - 5
ER -